Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era
在利妥昔单抗时代接受治疗的部分黑人免疫介导性血栓性血小板减少性紫癜（TTP）患者的无复发生存期逐渐缩短。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024013313
Fatola, Ayotola; Evans, Michael D; Brown, Jenna; Davis, Elizabeth; Johnson, Andrew; Antun, Ana G; Farland, Andrew M; Woods, Ryan; Metjian, Ara; Park, Yara A; de Ridder, Gustaaf; Gibson, Briana; Kasthuri, Raj S; Liles, Darla K; Eubanks, Susan; Akwaa, Frank; Clover, Todd; Kreuziger, Lisa Baumann; Sadler, J Evan; Sridharan, Meera; Go, Ronald S; McCrae, Keith R; Upreti, Harsh Vardhan; Lim, Ming Y; Kocher, Nicole K; Gangaraju, Radhika; Zheng, X Long; Raval, Jay S; Masias, Camila; Cataland, Spero R; Mazepa, Marshall; Chaturvedi, Shruti
